CYANOTECH CORPORATION
NASDAQ: CYAN (Cyanotech Corp.)
Last update: yesterday, 5:20PM0.252
-0.03 (-10.00%)
| Previous Close | 0.280 |
| Open | 0.280 |
| Volume | 3,500 |
| Avg. Volume (3M) | 5,379 |
| Market Cap | 1,825,044 |
| Price / Sales | 0.080 |
| Price / Book | 0.250 |
| 52 Weeks Range | |
| Earnings Date | 24 Jun 2025 - 30 Jun 2025 |
| Profit Margin | -13.23% |
| Operating Margin (TTM) | -7.18% |
| Diluted EPS (TTM) | -0.450 |
| Quarterly Revenue Growth (YOY) | 5.50% |
| Total Debt/Equity (MRQ) | 130.17% |
| Current Ratio (MRQ) | 1.03 |
| Operating Cash Flow (TTM) | -1.19 M |
| Levered Free Cash Flow (TTM) | 1.30 M |
| Return on Assets (TTM) | -6.16% |
| Return on Equity (TTM) | -30.95% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Packaged Foods (US) | Mixed | Bearish |
| Packaged Foods (Global) | Bearish | Bearish | |
| Stock | Cyanotech Corp. | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | 3.0 |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | 0.20 |
|
Cyanotech Corp is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The company's products include BioAstin Hawaiian Astaxanthin and Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. BioAstin Hawaiian Astaxanthin is a dietary antioxidant shown to support and maintain the body's natural inflammatory response, enhance skin, and support eye and joint health. It derives maximum revenue from the Packaged product and geographically from the United States. |
|
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
| Investment Style | Small Value |
| % Held by Insiders | 38.34% |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| DAVIS MICHAEL A / | 0.280 | - | 50,000 | 14,000 |
| MULDER DAVID M | 0.280 | - | 50,000 | 14,000 |
| VIED DAVID L | 0.280 | - | 50,000 | 14,000 |
| Aggregate Net Quantity | 150,000 | |||
| Aggregate Net Value ($) | 42,000 | |||
| Aggregate Avg. Buy ($) | 0.280 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| DAVIS MICHAEL A / | Director | 28 Aug 2025 | Acquired (+) | 50,000 | 0.280 | 14,000 |
| VIED DAVID L | Director | 28 Aug 2025 | Acquired (+) | 50,000 | 0.280 | 14,000 |
| MULDER DAVID M | Director | 28 Aug 2025 | Acquired (+) | 50,000 | 0.280 | 14,000 |
| Date | Type | Details |
|---|---|---|
| 20 Jun 2025 | Announcement | Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |